Is risk of central nervous system (CNS) relapse related to adjuvant taxane treatment in node-positive breast cancer? Results of the CNS substudy in the intergroup phase III BIG 02-98 trial
BC Pestalozzi, P Francis, E Quinaux, S Dolci, E Azambuja, RD Gelber, G Viale, A Balil, M Andersson, B Nordenskjoeld, M Gnant, J Gutierrez, I Lang, JPA Crown, M Piccart-Gebhart
ANNALS OF ONCOLOGY | OXFORD UNIV PRESS | Published : 2008
Awarded by National Health and Medical Research Council
Awarded by U. S. NCI
Australian New Zealand Breast Cancer Trials Group from National Health and Medical Research Council (100925 and 351164); U. S. NCI (CA-73362) to RDG; Swiss Group for Clinical Cancer Research.